Prucalopride clinical trials

Etude de phase II évaluant la capacité d'un agoniste des récepteurs 5-HT4, le prucalopride (Resolor©), à accélérer l'efficacité thérapeutique d'un antidépresseur de type ISRS: preuve de concept clinique.

This study looks at whether adding a drug called prucalopride to a common antidepressant (escitalopram) can help people with depression feel better faster. Researchers will compare how well people feel over six weeks when taking either prucalopride or a dummy pill alongside their antidepressant.